Four Cases of Carbapenem-Resistant Enterobacteriaceae Infection from January to March in 2014.
10.4082/kjfm.2015.36.4.191
- Author:
So Ri KIM
1
;
Chang Bun RIM
;
Younghun KIM
;
Jong Woo KIM
;
Young Woong SONG
;
Sang Ho SHIN
;
Hee Jung YOON
;
Sehoon SHIM
Author Information
1. Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea. yhj822@eulji.ac.kr
- Publication Type:Case Report
- Keywords:
Carbapenemase;
Enterobacteriaceae;
Enterobacter cloacae;
Drug Resistance, Bacterial
- MeSH:
Anti-Bacterial Agents;
Bacteria;
Centers for Disease Control and Prevention (U.S.);
Cephalosporins;
Delivery of Health Care;
Drug Resistance, Bacterial;
Education;
Enterobacter cloacae;
Enterobacteriaceae;
Enterobacteriaceae Infections*;
Hand Hygiene;
Korea;
Mass Screening;
Mortality;
Risk Factors;
Ventilators, Mechanical
- From:Korean Journal of Family Medicine
2015;36(4):191-194
- CountryRepublic of Korea
- Language:English
-
Abstract:
Infection with carbapenem-resistant Enterobacteriaceae (CRE) and other multidrug resistant bacteria has increased rapidly in Korea. The Korea Centers for Disease Control and Prevention reported 1,609 cases of CRE infection in the country in 2013. The risk factors for CRE infection include history of treatment with antibiotics such as cephalosporins or carbapenem, trauma, diabetes, cancer, and history of ventilator support. Herein, we report four cases of CRE infection seen during a 3-month period in our hospital in 2014. CRE infection is associated with a high mortality rate of 30% to 50%, even with combination antibiotic therapy. Prevention of CRE infection in hospital settings is fundamental to controlling its transmission. Key preventive measures include, contact precautions, hand hygiene, education of healthcare personnel, screening for CRE when indicated, and exercising discretion in prescribing carbapenem or cephalosporins.
